Cargando…

Clinical Presentations and Predictors of In-Hospital Mortality in Illicit Drug Users in the New Psychoactive Substances (NPS) Endemic Era in Taiwan

Predictors of mortality in illicit drug users involving Novel Psychoactive Substances (NPS) and multiple substances have not been elucidated. We aimed to define predictors of mortality in the NPS endemic era’s illicit drug users to strengthen patient care in emergency treatment. This was a retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeh, Hsin-Tzu, Chen, Hsien-Yi, Liu, Sung-Wei, Weng, Te-I, Fang, Cheng-Chung, Yu, Jiun-Hao, Chen, Yen-Chia, Su, Yu-Jang, Gao, Shi-Ying, Lin, Chih-Chuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317329/ https://www.ncbi.nlm.nih.gov/pubmed/35878292 http://dx.doi.org/10.3390/toxics10070386

Ejemplares similares

The Dynamic Environment of Crypto Markets: The Lifespan of New Psychoactive Substances (NPS) and Vendors Selling NPS
por: Wadsworth, Elle, et al.
Publicado: (2018)

Abuse of Licit and Illicit Psychoactive Substances in the Workplace: Medical, Toxicological, and Forensic Aspects
por: Dinis-Oliveira, Ricardo Jorge, et al.
Publicado: (2020)

Novel Psychoactive Substances (NPS): a Study on Persian Language Websites
por: BIGDELI, Imanollah, et al.
Publicado: (2013)

Investigation of New Psychoactive Substances (NPS), Other Illicit Drugs, and Drug-Related Compounds in a Taiwanese Wastewater Sample Using High-Resolution Mass-Spectrometry-Based Targeted and Suspect Screening
por: Chen, Yuan-Chih, et al.
Publicado: (2023)

Suicidality and self-injury behaviours due to the use of Novel Psychoactive Substances (NPS)
por: Orsolini, L.
Publicado: (2023)

Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS). A New Threat for Young Drug Users with Forensic-Toxicological Implications
por: Giorgetti, Arianna, et al.
Publicado: (2021)

Hair analysis for New Psychoactive Substances (NPS): Still far from becoming the tool to study NPS spread in the community?
por: Florou, Dimitra, et al.
Publicado: (2021)

New psychoactive substances in Taiwan: The current situation and initiative for rational scheduling
por: Yu, Wen-Jing, et al.
Publicado: (2021)

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review
por: Schifano, Fabrizio, et al.
Publicado: (2018)

Recent Changes in Drug Abuse Scenarios: The New/Novel Psychoactive Substances (NPS) Phenomenon
por: Schifano, Fabrizio
Publicado: (2018)

Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment
por: Specka, Michael, et al.
Publicado: (2020)

Analysis of Relationships between DAT1 Polymorphism Variants, Personality Dimensions, and Anxiety in New Psychoactive Substance (Designer Drug) (NPS) Users
por: Chmielowiec, Jolanta, et al.
Publicado: (2021)

Use of ecstasy and other psychoactive substances among school-attending adolescents in Taiwan: national surveys 2004–2006
por: Chen, Wei J, et al.
Publicado: (2009)

Data from roadside screening for psychoactive substances, alcohol and illicit drugs, among Spanish drivers in 2015
por: Herrero, Maria Jesús, et al.
Publicado: (2017)

Sales and Advertising Channels of New Psychoactive Substances (NPS): Internet, Social Networks, and Smartphone Apps
por: Miliano, Cristina, et al.
Publicado: (2018)

Corrigendum: Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment
por: Specka, Michael, et al.
Publicado: (2021)

Clinical characteristics in new psychoactive substance users: A single center study
por: Su, Yu-Jang, et al.
Publicado: (2023)

Health and Social Problems Associated with Recent Novel Psychoactive Substance (NPS) Use Amongst Marginalised, Nightlife and Online Users in Six European Countries
por: Van Hout, Marie Claire, et al.
Publicado: (2017)

Snapshot of narcotic drugs and psychoactive substances in Kuwait: analysis of illicit drugs use in Kuwait from 2015 to 2018
por: Al-Matrouk, Abdullah, et al.
Publicado: (2021)

Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants
por: Miliano, Cristina, et al.
Publicado: (2016)

The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: a systematic review protocol
por: Khaled, Salma M., et al.
Publicado: (2016)

EDITORIAL: New Psychoactive Substances (NPS), a New Global Issue: Neuropharmacological, Chemical and Toxicological Aspects
por: Pichini, Simona, et al.
Publicado: (2017)

Analyzing the Open/Deep Web to Better Understand the New/Novel Psychoactive Substances (NPS) Scenarios: Suggestions from CASSANDRA and NPS.Finder Research Projects
por: Schifano, Fabrizio
Publicado: (2020)

Running away experience and psychoactive substance use among adolescents in Taiwan: multi-city street outreach survey
por: Wang, Shi-Heng, et al.
Publicado: (2010)

Rapid Detection and Quantification of Novel Psychoactive Substances (NPS) Using Raman Spectroscopy and Surface-Enhanced Raman Scattering
por: Muhamadali, Howbeer, et al.
Publicado: (2019)

Awareness of users and motivational factors for using new psychoactive substances in Belgium
por: Simonis, Sarah, et al.
Publicado: (2020)

“Hot” and “Cold” Cognition in Users of Club Drugs/Novel Psychoactive Substances
por: Savulich, George, et al.
Publicado: (2021)

Internet interventions for adult illicit substance users: a meta‐analysis
por: Boumparis, Nikolaos, et al.
Publicado: (2017)

Undergraduate health profession students attitudes toward illicit substance users in Jordan
por: Abuhammad, Sawsan, et al.
Publicado: (2021)

Mechanistic Insights into the Stimulant Properties of Novel Psychoactive Substances (NPS) and Their Discrimination by the Dopamine Transporter—In Silico and In Vitro Exploration of Dissociative Diarylethylamines
por: Sahai, Michelle A., et al.
Publicado: (2018)

The Role of Dopamine in the Stimulant Characteristics of Novel Psychoactive Substances (NPS)—Neurobiological and Computational Assessment Using the Case of Desoxypipradrol (2-DPMP)
por: Loi, Barbara, et al.
Publicado: (2020)

Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project
por: Helander, Anders, et al.
Publicado: (2020)

Establishment of Neurotoxicity Assessment Using Microelectrode Array (MEA) with hiPSC-Derived Neurons and Evaluation of New Psychoactive Substances (NPS)
por: Kang, Kyu-ree, et al.
Publicado: (2022)

In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters
por: Botha, Michelle J., et al.
Publicado: (2022)

ANALYTICALLY CONFIRMED PRESENCE OF PSYCHOACTIVE SUBSTANCES, ESPECIALLY NEW PSYCHOACTIVE SUBSTANCES IN A GROUP OF PATIENTS HOSPITALIZED WITH MENTAL AND BEHAVIOURAL DISORDERS DUE TO THE USE OF PSYCHOACTIVE SUBSTANCES DIAGNOSIS
por: Engelgardt, Piotr, et al.
Publicado: (2022)

Stealth-vaping: a new era of illicit substance misuse? a systematic review and meta-analysis of the prevalence of electronic nicotine delivery systems for the consumption of illicit substances
por: Hicks, Tim, et al.
Publicado: (2021)

Illicit substances identified in the urine of 11.170 suspected drug users in North Tunisia
por: Chaouali, Nadia, et al.
Publicado: (2021)

Differences between users’ and addiction medicine experts’ harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates
por: Bonnet, Udo, et al.
Publicado: (2022)

Novel Psychoactive Substances and Behavioral Addictions
por: Martinotti, Giovanni, et al.
Publicado: (2014)

Editorial: Pharmacology of new psychoactive substances
por: Lutfy, K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_isa836vkssb33qto6objudi21l